Evaluation of the CRISPR/Cas9 system as genome editing platform for the Mucopolysaccharidosis IV A using a strategy for induction of higher homologous recombination frequency. Univ. Sci. [Internet]. 2025 Apr. 24 [cited 2025 May 13];30:82-106. Available from: https://revistas.javeriana.edu.co/index.php/scientarium/article/view/39188